Evidence map›Paper›PMID 38158555›Full record

ReviewJournal of physiology and biochemistry2024

N6-methyladenosine in myeloid cells: a novel regulatory factor for inflammation-related diseases.

Jin Pang, Tong-Dong Kuang, Xin-Yuan Yu, Petr Novák, Yuan Long, Min Liu, Wei-Qian Deng, Xiao Zhu, Kai Yin

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of physiology and biochemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. mFrontiers in immunology · 2026
    Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jin PangGuangxi Key Laboratory of Diabetic Systems Medicine, Guilin Medical University, Guilin, Guangxi, China.
Tong-Dong KuangGuangxi Key Laboratory of Diabetic Systems Medicine, Guilin Medical University, Guilin, Guangxi, China.
Xin-Yuan YuGuangxi Key Laboratory of Diabetic Systems Medicine, Guilin Medical University, Guilin, Guangxi, China.
Petr NovákGuangxi Key Laboratory of Diabetic Systems Medicine, Guilin Medical University, Guilin, Guangxi, China.
Yuan LongDepartment of General Practice, The Fifth Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China.
Min LiuDepartment of General Practice, The Fifth Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China.
Wei-Qian DengDepartment of General Practice, The Fifth Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China.
Xiao ZhuGuangxi Key Laboratory of Diabetic Systems Medicine, Guilin Medical University, Guilin, Guangxi, China. 1365681080@qq.com.
Kai YinDepartment of General Practice, The Fifth Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong, China. kaiyinby@qq.com.ORCID http://orcid.org/0009-0000-4467-8962

Funding

Natural Science Foundation of Guangxi Zhuang Autonomous Region 2020GXNSFDA297011
6 · The paper itself

Abstract

N6-methyladenosine (m

Indexed as

AdenosineInflammationMyeloid CellsAnimalsAutoimmune DiseasesHumansMetabolic DiseasesNeoplasmsAdenosineN-methyladenosineInflammation-related diseasesMyeloid cellsN6-methyladenosine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.